Healthcare

Senate File 304 amends existing law concerning a minor's ability to consent to medical care related to sexually transmitted diseases (STDs). Currently, minors can independently consent to medical care or services for the prevention, diagnosis, or treatment of STDs. This bill introduces a specific exception to that provision. Under SF 304, a minor will no longer have the legal capacity to consent to the provision of a vaccination for a sexually transmitted disease or infection without the consent of another person, such as a parent or guardian.

SF 615 adds work requirements for participants in Iowa's health and wellness plan and Medicaid for employed people with disabilities, directly affecting eligible residents receiving these specific public assistance benefits. The bill requires individuals to meet certain work or training hours to maintain eligibility, alongside provisions for related funding mechanisms like the information technology fund and public assistance modernization fund. It became law after the Governor signed it on June 6, 2025, implementing these new eligibility conditions for the specified programs. The policy change modifies existing program rules without altering benefit amounts or creating new programs.

HF 972, now law after Governor's signature on May 28, 2025, establishes a new funding model for Iowa's rural healthcare systems while eliminating several existing health care programs. It removes specific award, grant, residency, and fellowship programs, and creates a new incentive program to attract healthcare professionals to underserved areas. The bill also modifies Medicaid funding for graduate medical education, updates the Health Facilities Council, and addresses the Iowa Health Information Network, with all changes including necessary funding appropriations. These changes directly affect rural health providers, medical training programs, and state health agencies managing these systems.

SF 383 requires pharmacy benefits managers (PBMs) to disclose drug pricing details and standardized fee structures to pharmacies and insurers. It limits certain PBM practices that affect prescription drug costs and establishes transparency rules for pharmacy services administrative organizations. The law directly affects PBMs, pharmacies, and insurance companies managing prescription drug benefits. Signed into law by the Governor on June 6, 2025, it aims to increase transparency in drug pricing and pharmacy billing.